Loading
institutionsInstitution
Tawam Hospital
The UAE's national referral hospital for cancer, with the country's first comprehensive oncology institute, bone marrow transplant service and long-standing Johns Hopkins affiliation.
Also called: Tawam Hospital Oncology InstituteSEHA Tawamمستشفى توام
Overview
Tawam Hospital in Al Ain, opened in 1979 and now part of PureHealth/SEHA and the Abu Dhabi health system, is the UAE's designated national referral centre for oncology and hosts its longest-established comprehensive cancer programme, with medical, surgical and radiation oncology, paediatric oncology, nuclear medicine and the country's first bone marrow transplant service. It was managed for many years in affiliation with Johns Hopkins Medicine and is the main teaching hospital of the United Arab Emirates University College of Medicine, contributing to the UAE national cancer registry and to research on breast cancer in young Arab women, colorectal screening and hereditary cancer. Tawam anchors the Abu Dhabi cancer care network alongside Cleveland Clinic Abu Dhabi.
Location
Al Ain, AE
Type
hospital · United Arab Emirates University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#344 · 20 points (0 Newsweek + 0 NCI + 20 from 10 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Tawam Hospital, including child institutions. 72 works · 905 citations · 79% open access · 8% clinical trials · 10% reviews.
Oncology works per year
172022
72023
182024
192025
112026
Most works
- Selvaraj Giridharan11 works
- Aydah Al‐Awadhi7 works
- Jawaher Ansari6 works
- Mohammad Hourani5 works
- Lina Wahba5 works
- Mouza Al Ameri5 works
- Yauhen Statsenko4 works
- Fatima AlKindi4 works
- Iryna Makhnevych4 works
- Khalid Balaraj4 works
Most cited
- National oncology referral centre
- Bone marrow transplant
- Paediatric oncology
- UAE cancer registry
Similar pages
- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Allogeneic (off-the-shelf) cell therapy, Thyroid cancer, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionTata Medical Center, Kolkata
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
- InstitutionKing Hussein Cancer Center
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- CompanyImugene
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia.
- InstitutionRambam Health Care Campus
Shares Allogeneic (off-the-shelf) cell therapy, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionInstituto Português de Oncologia de Lisboa Francisco Gentil
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
- InstitutionNational Cancer Institute, Cairo University
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.